These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17093961)

  • 1. Reporting results of biomonitoring studies.
    Foster WG; Agzarian J
    Anal Bioanal Chem; 2007 Jan; 387(1):137-40. PubMed ID: 17093961
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons learnt on recruitment and fieldwork from a pilot European human biomonitoring survey.
    Fiddicke U; Becker K; Schwedler G; Seiwert M; Joas R; Joas A; Biot P; Aerts D; Casteleyn L; Dumez B; Castaño A; Esteban M; Angerer J; Koch HM; Schoeters G; Den Hond E; Sepai O; Exley K; Knudsen LE; Horvat M; Bloemen L; Katsonouri A; Hadjipanayis A; Cerna M; Krsková A; Jensen JF; Nielsen JK; Rudnai P; Közepésy S; Gutleb AC; Fischer ME; Ligocka D; Kamińska J; Reis MF; Namorado S; Lupsa IR; Gurzau AE; Halzlová K; Mazej D; Tratnik JS; Rivas TC; Gómez S; Berglund M; Larsson K; Lehmann A; Crettaz P; Dewolf MC; Burns D; Kellegher A; Kolossa-Gehring M
    Environ Res; 2015 Aug; 141():15-23. PubMed ID: 25454101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting results of human biomonitoring of environmental chemicals to study participants: a comparison of approaches followed in two Canadian studies.
    Haines DA; Arbuckle TE; Lye E; Legrand M; Fisher M; Langlois R; Fraser W
    J Epidemiol Community Health; 2011 Mar; 65(3):191-8. PubMed ID: 20628082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context.
    St-Amand A; Werry K; Aylward LL; Hays SM; Nong A
    Toxicol Lett; 2014 Dec; 231(2):126-34. PubMed ID: 25455445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concept of the Flemish human biomonitoring programme.
    Schoeters G; Den Hond E; Colles A; Loots I; Morrens B; Keune H; Bruckers L; Nawrot T; Sioen I; De Coster S; Van Larebeke N; Nelen V; Van de Mieroop E; Vrijens J; Croes K; Goeyens K; Baeyens W
    Int J Hyg Environ Health; 2012 Feb; 215(2):102-8. PubMed ID: 22178406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting and evaluation criteria as means towards a transparent use of ecotoxicity data for environmental risk assessment of pharmaceuticals.
    Ågerstrand M; Küster A; Bachmann J; Breitholtz M; Ebert I; Rechenberg B; Rudén C
    Environ Pollut; 2011 Oct; 159(10):2487-92. PubMed ID: 21763042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informed consent or acknowledgment of disclosure.
    Reidenberg MM
    Clin Pharmacol Ther; 2005 Oct; 78(4):439-40. PubMed ID: 16198663
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethics in biomonitoring for occupational health.
    Manno M; Sito F; Licciardi L
    Toxicol Lett; 2014 Dec; 231(2):111-21. PubMed ID: 25447455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring equivalents for inorganic arsenic.
    Hays SM; Aylward LL; Gagné M; Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):1-9. PubMed ID: 20547195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomonitoring Equivalents for bisphenol A (BPA).
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):18-24. PubMed ID: 20541576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guest Editorial. Harmonized human biomonitoring on a European scale: experiences in seventeen countries.
    Casteleyn L; Aerts D
    Environ Res; 2015 Aug; 141():1-2. PubMed ID: 26253856
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ethical considerations on the planning, assessment and management of biological monitoring data].
    Van Damme K; Casteleyn L; Manno M
    G Ital Med Lav Ergon; 2004; 26(4):338-43. PubMed ID: 15584443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why IRIS is outdated: an additional perspective.
    Graham J
    Risk Anal; 2006 Dec; 26(6):1411-2. PubMed ID: 17184385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expertise in the testing and introduction of risk assessment methodologies].
    Katsnel'son BA; Privalova LI; Kuz'min SV; Nikonov BI; Gurvich VB
    Gig Sanit; 2002; (6):69-71. PubMed ID: 12516145
    [No Abstract]   [Full Text] [Related]  

  • 15. IRIS from the inside.
    Mills A
    Risk Anal; 2006 Dec; 26(6):1409-10; discussion 1413. PubMed ID: 17184384
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomonitoring equivalents for hexachlorobenzene.
    Aylward LL; Hays SM; Gagné M; Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):25-32. PubMed ID: 20547196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomonitoring Equivalents for triclosan.
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):10-7. PubMed ID: 20541577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological monitoring guidance values for chemical incidents.
    Cocker J; Jones K; Bos PM
    Toxicol Lett; 2014 Dec; 231(3):324-7. PubMed ID: 24973493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new spin on research translation: the Boston Consensus Conference on Human Biomonitoring.
    Nelson JW; Scammell MK; Altman RG; Webster TF; Ozonoff DM
    Environ Health Perspect; 2009 Apr; 117(4):495-9. PubMed ID: 19440485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
    Boogaard PJ; Hays SM; Aylward LL
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.